Interplay of intestinal microbiota and mucosal immunity in inflammatory bowel disease: a relationship of frenemies
Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn’s disease, are chronic inflammatory disorders of the gastrointestinal tract. With in-depth studies on the mechanisms of the initiation and development of IBD, increasing lines of evidence have focused on the intestinal microb...
Main Authors: | Huimin Chen, Hongfen Li, Zhanju Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-09-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756284820935188 |
Similar Items
-
Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease
by: Guangxi Zhou, et al.
Published: (2016-01-01) -
Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease
by: Gengfeng Li, et al.
Published: (2021-01-01) -
The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases
by: Nikolas Dovrolis, et al.
Published: (2020-03-01) -
The Interplay Between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
by: Laila Aldars-García, et al.
Published: (2021-03-01) -
A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease.
by: Maomeng Tong, et al.
Published: (2013-01-01)